Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.205 USD | +2.08% | +5.00% | -26.25% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.25% | 409M | |
+41.92% | 739B | |
+32.52% | 598B | |
-5.65% | 353B | |
+17.50% | 318B | |
+4.47% | 285B | |
+16.45% | 240B | |
+9.78% | 210B | |
-5.19% | 206B | |
+7.44% | 164B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise